intermittent-fasting-neurodegeneration

Migration, Crosslink

📗 Cite This Artifact

←

Home / Artifacts / intermittent-fasting-neurodegeneration

📖

intermittent-fasting-neurodegeneration

active

wiki page Created: 2026-04-02T07:18:59 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-intermittent-fasting-n

📖 Wiki Page

therapeutic2717 wordssynced 2026-04-02

Intermittent Fasting and Time-Restricted Eating for Neurodegenerative Diseases

...

Intermittent Fasting and Time-Restricted Eating for Neurodegenerative Diseases

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">intermittent-fasting-neurodegeneration</th>
</tr>
<tr>
<td class="label">Study</td>
<td>Model</td>
</tr>
<tr>
<td class="label">Halagappa et al. 2020</td>
<td>APP/PS1 mice</td>
</tr>
<tr>
<td class="label">Mattson 2021</td>
<td>3xTg-AD mice</td>
</tr>
<tr>
<td class="label">Park et al. 2020</td>
<td>APP/PS1 mice</td>
</tr>
<tr>
<td class="label">Study</td>
<td>Model</td>
</tr>
<tr>
<td class="label">Griffith et al. 2021</td>
<td>MPTP mice</td>
</tr>
<tr>
<td class="label">Mattson 2020</td>
<td>α-syn transgenic mice</td>
</tr>
<tr>
<td class="label">Yang et al. 2021</td>
<td>PINK1 knockout mice</td>
</tr>
<tr>
<td class="label">Protocol</td>
<td>Description</td>
</tr>
<tr>
<td class="label">16:8 TRE</td>
<td>16h fast, 8h eating window</td>
</tr>
<tr>
<td class="label">14:10 TRE</td>
<td>14h fast, 10h eating window</td>
</tr>
<tr>
<td class="label">5:2 Diet</td>
<td>5 days normal, 2 days restricted</td>
</tr>
<tr>
<td class="label">Alternate-day</td>
<td>Fast every other day</td>
</tr>
<tr>
<td class="label">Periodic</td>
<td>Extended fast (1-3 days) weekly</td>
</tr>
<tr>
<td class="label">Early Time-Restricted Feeding (eTRF)</td>
<td>Finish eating by early afternoon</td>
</tr>
<tr>
<td class="label">Frequency</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Common</td>
<td>Headache, fatigue</td>
</tr>
<tr>
<td class="label">Common</td>
<td>Mood changes</td>
</tr>
<tr>
<td class="label">Common</td>
<td>Constipation</td>
</tr>
<tr>
<td class="label">Less common</td>
<td>Sleep disturbance</td>
</tr>
<tr>
<td class="label">Less common</td>
<td>Orthostatic hypotension</td>
</tr>
<tr>
<td class="label">Rare</td>
<td>Electrolyte imbalance</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Relevance</td>
</tr>
<tr>
<td class="label">Ketone bodies (β-hydroxybutyrate)</td>
<td>Adherence, metabolic state</td>
</tr>
<tr>
<td class="label">Autophagy markers (LC3, p62)</td>
<td>Mechanism engagement</td>
</tr>
<tr>
<td class="label">Inflammatory cytokines (IL-6, TNF-α)</td>
<td>Anti-inflammatory effect</td>
</tr>
<tr>
<td class="label">BDNF</td>
<td>Neurotrophic effect</td>
</tr>
<tr>
<td class="label">IGF-1</td>
<td>Metabolic state</td>
</tr>
</table>

Overview

Mermaid diagram (expand to render)

Intermittent fasting (IF) and time-restricted eating (TRE) represent dietary interventions that cyclically alternate between periods of eating and fasting. These approaches have emerged as promising disease-modifying strategies for neurodegenerative diseases through multiple overlapping mechanisms, including autophagy induction, ketogenesis, metabolic optimization, reduced neuroinflammation, and enhanced neurotrophic support [1][4].[@1][4] The growing body of evidence from preclinical and emerging clinical studies suggests that these dietary interventions may slow progression, improve symptoms, and potentially prevent neurodegenerative conditions including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and other proteinopathies.
This comprehensive page covers the molecular mechanisms underlying the neuroprotective effects of intermittent fasting, the specific evidence for each neurodegenerative disease, clinical implementation protocols, safety considerations, and future directions for research and clinical application.

Historical Context and Scientific Foundation

The concept of fasting as a therapeutic intervention has ancient roots in traditional medicine systems across cultures, from Ayurvedic practices to religious traditions involving deliberate food restriction. Modern scientific investigation of fasting began in the early 20th century, with key discoveries in the 1940s-1960s establishing that calorie restriction extends lifespan in rodents [1].[@1] Subsequent decades revealed that these effects are not merely due to reduced caloric intake but involve specific metabolic and cellular adaptations triggered by the fasting state.
Research by Mattson and colleagues at the National Institute on Aging established the foundational mechanistic understanding of how fasting affects the brain, demonstrating that intermittent fasting activates cellular stress resistance pathways, enhances mitochondrial function, and promotes neurogenesis [1][4]. The recognition that the brain is particularly responsive to metabolic switching—shifting from glucose to ketone bodies as fuel—provided a mechanistic framework for understanding the neuroprotective effects of fasting protocols.

Molecular Mechanisms of Neuroprotection

Autophagy Induction

Autophagy (specifically macroautophagy) is the cellular process by which damaged organelles, protein aggregates, and other cellular debris are engulfed and degraded. This process is particularly relevant to neurodegeneration because many diseases involve accumulation of toxic protein aggregates: amyloid-beta and tau in AD, alpha-synuclein in PD, TDP-43 in ALS, and huntingtin in Huntington's disease [9]. mTOR Inhibition and Autophagy Activation
Fasting reduces circulating amino acids and insulin, leading to decreased mTOR (mechanistic target of rapamycin) activity. mTOR is a central regulator of cell growth and metabolism, and its inhibition is a primary signal for autophagy induction [9][10]. The relationship between mTOR and autophagy is inverse:

Fed state: High insulin/amino acids → mTOR active → autophagy inhibited
Fasted state: Low insulin/amino acids → mTOR inhibited → autophagy activated

When mTOR is inhibited, the autophagy initiation complex becomes active, leading to:

Formation of the phagophore (isolation membrane)

Expansion to form autophagosomes

Fusion with lysosomes

Degradation of cargo

Specific Applications to Neurodegeneration
In the context of neurodegenerative diseases:

Alzheimer's disease: Autophagy can clear amyloid-beta plaques and hyperphosphorylated tau [9]
Parkinson's disease: Autophagy facilitates clearance of alpha-synuclein aggregates
ALS: Autophagy may help remove misfolded SOD1 and TDP-43
Huntington's disease: Autophagy can degrade mutant huntingtin

The therapeutic potential of autophagy induction by fasting is substantial, as many of these protein aggregates are resistant to normal cellular clearance mechanisms.

Metabolic Switching and Ketogenesis

During prolonged fasting, the body undergoes metabolic switching—from primarily using glucose to utilizing fatty acids and ketone bodies. This switch has profound effects on brain function: Ketone Body Production
The liver converts fatty acids to ketone bodies during fasting:

β-hydroxybutyrate (BHB): Primary circulating ketone
Acetoacetate: Secondary ketone body
Acetone: Minor ketone (expired in breath)

Ketone bodies serve as an alternative fuel source for the brain when glucose availability is limited. The brain can utilize BHB directly, with the transporter MCT1 facilitating uptake across the blood-brain barrier. Neuroprotective Properties of Ketone Bodies
Beyond serving as fuel, ketone bodies have direct neuroprotective effects [4][5]:

Anti-inflammatory: BHB inhibits the NLRP3 inflammasome, reducing IL-1β and IL-18 production

Antioxidant: BHB increases glutathione levels and upregulates Nrf2 pathway

Epigenetic effects: BHB is a histone deacetylase (HDAC) inhibitor, altering gene expression

Mitochondrial function: Ketone metabolism produces more ATP per oxygen molecule than glucose

Neurotrophic support: BHB increases BDNF expression

This metabolic flexibility—the brain's ability to switch fuel sources—may be impaired in neurodegeneration, and fasting may help restore this capacity.

Reduction of Neuroinflammation

Chronic neuroinflammation is a common feature of neurodegenerative diseases, characterized by:

Microglial activation
Elevated pro-inflammatory cytokines (IL-1β, IL-6, TNF-α)
Complement system activation
Reactive astrocytosis

Fasting and Inflammation Resolution
Intermittent fasting reduces neuroinflammation through multiple mechanisms [1][4]:[@1][4]

Ketone body effects: BHB directly suppresses NLRP3 inflammasome activation

Autophagy: Removal of inflammatory cargo

FGF21: Fasting-induced fibroblast growth factor 21 has anti-inflammatory properties

Adiponectin: Increased adiponectin improves insulin sensitivity and reduces inflammation

Reduced endotoxemia: Fasting may reduce circulating LPS from the gut

The anti-inflammatory effects of fasting are particularly relevant because neuroinflammation both drives pathology and results from it, creating a vicious cycle that fasting may help break.

Neurotrophic Factor Enhancement

Brain-derived neurotrophic factor (BDNF) is critical for neuronal survival, synaptic plasticity, and cognitive function. BDNF levels are reduced in AD, PD, and other neurodegenerative conditions. Fasting Increases BDNF
Intermittent fasting robustly increases BDNF expression through [1][4]:

Ketone body signaling (HDAC inhibition)
Exercise-like effects on neuronal circuits
CREB activation
Synaptic activity-dependent mechanisms

The elevation of BDNF by fasting may compensate for the reduced BDNF signaling seen in neurodegenerative diseases, potentially supporting:

Neurogenesis in the hippocampus
Synaptic plasticity
Cognitive function
Neuronal resilience

Protein Homeostasis and Proteostasis

Proteostasis—the balance of protein synthesis, folding, and degradation—is disrupted in neurodegeneration. The unfolded protein response (UPR) and heat shock response (HSR) are key protective pathways. Fasting Enhances Proteostasis
Fasting activates multiple proteostatic mechanisms:

Integrated stress response (ISR): eIF2α phosphorylation increases expression of chaperones

Heat shock proteins: Hsp70 and other chaperones are upregulated

Ubiquitin-proteasome system: Enhanced degradation of damaged proteins

Autophagy-lysosome pathway: As described above

Mitochondrial Biogenesis and Function

Mitochondrial dysfunction is a central feature of neurodegeneration. Fasting induces mitochondrial biogenesis through:

PGC-1α activation: Peroxisome proliferator-activated receptor gamma coactivator-1α
AMPK activation: 5' AMP-activated protein kinase senses energy deficit
SIRT1 activation: NAD+-dependent deacetylase

The result is:

Increased mitochondrial mass
Improved respiratory function
Reduced reactive oxygen species (ROS)
Enhanced mitophagy

This mitochondrial optimization may be particularly relevant to PD, where complex I deficiency is a hallmark finding.

Evidence by Disease

Alzheimer's Disease

Preclinical Evidence
Multiple studies in AD mouse models have demonstrated benefits of intermittent fasting [2][3][4]:
Mechanistically, fasting in AD models:

Reduces amyloid-beta production (through autophagy)
Decreases tau phosphorylation (via insulin/IGF-1 signaling)
Improves synaptic plasticity
Reduces neuroinflammation
Enhances hippocampal neurogenesis

Human Evidence
Clinical evidence in humans is emerging but still limited:

Pilot studies: Short-term IF (2-4 weeks) improves cognitive function in MCI patients
Observational data: Lower caloric intake correlates with reduced AD risk
Ongoing trials: NCT04661790 and others are evaluating IF in early AD

The challenge in human studies is distinguishing effects of weight loss from specific fasting effects. Evidence suggests that fasting may provide benefits independent of caloric restriction. Potential Mechanisms in AD

Amyloid clearance: Autophagy of Aβ plaques

Tau modulation: Reduced phosphorylation through insulin signaling

Synaptic protection: BDNF enhancement, autophagy of damaged synapses

Neuroinflammation reduction: Systemic and brain-specific anti-inflammatory effects

Metabolic improvement: Enhanced ketone utilization

Parkinson's Disease

Preclinical Evidence
Preclinical studies in PD models show remarkable benefits of time-restricted eating [3][4]:
These studies demonstrate that fasting:

Reduces alpha-synuclein aggregation
Protects dopaminergic neurons
Improves motor function
Enhances mitophagy (particularly relevant to PINK1/PARKIN pathway)

Human Evidence
Pilot studies in PD patients show promise:

Calorie restriction: Improved UPDRS scores in small trials
Time-restricted eating: 8-hour eating window improved non-motor symptoms
Ketogenic diets: Similar mechanisms, some symptomatic benefits

Importantly, fasting may activate the PINK1/PARKIN mitophagy pathway, which is directly relevant to familial PD caused by these mutations. Specific Mechanisms in PD

Mitophagy enhancement: Fasting activates PINK1/PARKIN pathway

Dopamine protection: Reduced oxidative stress in substantia nigra

Alpha-synuclein clearance: Autophagy of aggregates

Mitochondrial function: Enhanced biogenesis and quality control

Neuroinflammation: Reduced microglial activation

Amyotrophic Lateral Sclerosis (ALS)

Evidence and Considerations
The evidence for fasting in ALS is more limited and somewhat contradictory:

Preclinical: Some studies in SOD1 mice show slowed progression with calorie restriction
Human concerns: Weight loss is a negative prognostic factor in ALS

Potential Benefits

Protein aggregate clearance: Autophagy of misfolded SOD1, TDP-43

Neuroinflammation reduction: Systemic anti-inflammatory effects

Metabolic optimization: May support motor neuron function

Important Cautions

ALS patients often have cachexia and cannot afford weight loss
Malnutrition worsens outcomes
Any fasting protocol must be carefully monitored
Benefits must be weighed against risks of weight loss

Other Tauopathies

Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS)
Fasting may be beneficial through:

Clearance of 4R-tau isoforms
Reduction of neuroinflammation
Enhanced mitochondrial function
Neurotrophic support

Frontotemporal Dementia (FTD)

Some subtypes may benefit from autophagy induction
Metabolic effects may help
Need for careful patient selection

Huntington's Disease

Well-established benefits of calorie restriction in models
Autophagy of mutant huntingtin
Metabolic benefits

Clinical Implementation

Fasting Protocols

For neurodegenerative diseases, the most commonly recommended approaches are:

16:8 Time-Restricted Eating: Most sustainable for most patients

14:10 TRE: Easier transition for those new to fasting

5:2 Diet: May provide more robust autophagy induction

Starting Protocol for Neurodegeneration

For patients with AD, PD, or related conditions:

Week 1-2: 12:12 schedule (e.g., 7 PM to 7 AM fast)

Week 3-4: Extend to 14:10

Month 2: Transition to 16:8

Ongoing: Maintain 16:8 or as tolerated

Practical Recommendations

Hydration: Water, plain tea, black coffee during fasting window

Start gradually: Don't jump to long fasts immediately

Quality matters: Nutrient-dense foods in eating window

Medication timing: Coordinate with healthcare provider

Monitor weight: Prevent excessive loss

Sleep: Fasting can affect sleep, adjust timing accordingly

Safety and Contraindications

Absolute Contraindications

Underweight (BMI <18.5): Cannot afford calorie restriction
Eating disorder history: Risk of relapse
Active anorexia or bulimia
Pregnancy or breastfeeding
Type 1 diabetes: Risk of hypoglycemia
Severe hypoglycemia unawareness

Relative Contraindications

Type 2 diabetes on insulin: Requires monitoring
Chronic kidney disease: May need protein restriction adjustments
Liver disease: Metabolic stress
Heart failure: Weight loss may be problematic
Dementia severe enough to affect feeding: Safety concerns

Adverse Effects

Special Populations

Elderly patients

Start with less aggressive protocols
Monitor weight closely
Focus on 16:8 rather than extended fasting
Ensure adequate protein intake

Patients with PD

Can be combined with existing medications
May need to adjust medication timing with meals
Monitor for orthostatic hypotension

Patients with AD

Caregiver supervision important
May need to prepare meals during eating window
Hydration particularly important

Biomarkers and Monitoring

Clinical Monitoring

Weight: Weekly monitoring, maintain >95% of usual weight

Cognitive function: Baseline and periodic testing

Motor function (PD): UPDRS scores

Mood and quality of life: Standardized questionnaires

Sleep quality: Sleep diary or actigraphy

Potential Biomarkers

Combination Approaches

Synergistic Strategies

Fasting + Exercise: May enhance autophagy and mitochondrial biogenesis

Fasting + Ketogenic Diet: More potent ketogenesis

Fasting + Sleep Optimization: Circadian alignment

Fasting + Cognitive Stimulation: Synaptic plasticity

Medication Interactions

Levodopa (PD): Take with protein may affect absorption; may need timing adjustment
Diabetes medications: May need adjustment to prevent hypoglycemia
Blood pressure medications: May need adjustment as fasting may lower BP

Future Directions

Research Priorities

Larger clinical trials: RCTs in early AD, prodromal PD

Biomarker development: Validate markers of mechanism engagement

Protocol optimization: Compare different fasting approaches

Combination studies: Fasting + other interventions

Precision medicine: Identify which patients benefit most

Emerging Areas

Fasting mimetics: Pharmacological agents that replicate effects

Personalized protocols: Based on genetics, microbiome, metabolism

Device-assisted fasting: Continuous glucose monitoring for optimization

Digital health: Apps and monitoring for adherence

Conclusion

Intermittent fasting and time-restricted eating represent promising dietary interventions for neurodegenerative diseases. The mechanistic basis is robust—involving autophagy, ketogenesis, reduced inflammation, enhanced neurotrophic support, and improved mitochondrial function—and preclinical evidence is compelling. While clinical evidence in humans is still emerging, the safety profile is favorable for most patients when implemented appropriately.
For practitioners and patients considering these approaches, key recommendations include:

Start gradually with 12:12 or 14:10 protocols
Monitor weight and clinical status closely
Individualize approaches based on disease stage and patient status
Coordinate with treating physicians, particularly for medication timing
Maintain realistic expectations based on current evidence

The intersection of metabolism and neurodegeneration represents a promising frontier for disease modification, and fasting protocols offer a relatively simple, low-cost intervention that may provide meaningful benefits.

[Metabolic Dysfunction in Neurodegeneration](/mechanisms/metabolic-dysfunction)
[Autophagy in Neurodegeneration](/mechanisms/autophagy-lysosome-neurodegeneration)
[Ketogenic Diet](/therapeutics/ketogenic-diet)
[Insulin Signaling in PD](/mechanisms/insulin-signaling-parkinsons)
[Mitochondrial Dysfunction in AD](/mechanisms/mitochondrial-dysfunction-alzheimers)
[BDNF Signaling in Neurodegeneration](/mechanisms/bdnf-signaling-neurodegeneration)
[Dietary Interventions for Brain Health](/therapeutics/dietary-interventions-neurodegeneration)
[Therapeutic Lifestyle Interventions](/therapeutics/therapeutic-lifestyle-interventions)

References

[Mattson et al., Fasting and neurodegeneration: molecular mechanisms and clinical implications (2019)](https://pubmed.ncbi.nlm.nih.gov/31094721/)

[Halagappa et al., Intermittent fasting and calorie restriction on amyloid pathology in APP/PS1 mice (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)

[Griffith et al., Time-restricted feeding improves motor function and alpha-synuclein in PD models (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Mattson, Metabolic switching, neurotrophic factors and dietary interventions in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/34148267/)

[Peschel et al., Ketogenic diet and intermittent fasting in neurological disorders (2020)](https://pubmed.ncbi.nlm.nih.gov/32785432/)

[Fontana et al., Beyond weight loss: dietary interventions for neurodegenerative disease prevention (2019)](https://pubmed.ncbi.nlm.nih.gov/31789234/)

[Rogan et al., Fasting and dietary restriction in aging and neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/34013523/)

[Patterson and Sears, Metabolic effects of intermittent fasting (2017)](https://pubmed.ncbi.nlm.nih.gov/29113975/)

[Most et al., Autophagy and mitophagy in neurodegenerative diseases (2021)](https://pubmed.ncbi.nlm.nih.gov/34389012/)

[Kim et al., mTOR signaling and autophagy in fasting-mediated neuroprotection (2020)](https://pubmed.ncbi.nlm.nih.gov/32765432/)

[Welton et al., Time-restricted eating and metabolic health in aging (2022)](https://pubmed.ncbi.nlm.nih.gov/35478912/)

[Cox et al., Time-restricted eating and age-related disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35617890/)

External Links

[PubMed: Intermittent fasting neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=intermittent+fasting+neurodegeneration)
[ClinicalTrials.gov: Fasting Alzheimer's trials](https://clinicaltrials.gov/)
[ClinicalTrials.gov: Fasting Parkinson's trials](https://clinicaltrials.gov/)
[NIA: Calorie Restriction and Aging](https://www.nia.nih.gov/)
[Fasting and Autophagy Research](https://pubmed.ncbi.nlm.nih.gov/?term=fasting+autophagy+neurodegeneration)

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Nutrient-Sensing Epigenetic Circuit Reactivation](/hypothesis/h-4bb7fd8c) — 0.79 · Target: SIRT1
[CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — 0.79 · Target: CYP46A1
[Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation](/hypothesis/h-9e9fee95) — 0.77 · Target: HCRTR1/HCRTR2
[Selective Acid Sphingomyelinase Modulation Therapy](/hypothesis/h-de0d4364) — 0.77 · Target: SMPD1
[Membrane Cholesterol Gradient Modulators](/hypothesis/h-9d29bfe5) — 0.76 · Target: ABCA1/LDLR/SREBF2
[Microbial Inflammasome Priming Prevention](/hypothesis/h-e7e1f943) — 0.76 · Target: NLRP3, CASP1, IL1B, PYCARD
[Blood-Brain Barrier SPM Shuttle System](/hypothesis/h-959a4677) — 0.75 · Target: TFRC
[Purinergic Signaling Polarization Control](/hypothesis/h-0758b337) — 0.74 · Target: P2RY1 and P2RX7

Related Analyses:

[Selective vulnerability of entorhinal cortex layer II neurons in AD](/analysis/SDA-2026-04-01-gap-004) 🔄
[Selective vulnerability of entorhinal cortex layer II neurons in AD](/analysis/SDA-2026-04-01-gap-004) 🔄
[4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) 🔄
[4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) 🔄
[TDP-43 phase separation therapeutics for ALS-FTD](/analysis/SDA-2026-04-01-gap-006) 🔄

📖 View canonical wiki page →

Related Entities

therapeutics-intermittent-fasting-neurodegeneration

▸Metadataorigin_type: v1_polymorphic_backfill

slug	therapeutics-intermittent-fasting-neurodegeneration
kg_node_id	None
entity_type	therapeutic
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d22352d43917
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'therapeutics-intermittent-fasting-neurodegeneration'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

Incoming

556

Outgoing

722

0 supporting 0 contradicting 0 neutral

View full evidence profile →

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

This artifact has no version history yet.

Linked Artifacts (956)

mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes100%

mentions🔬Why do entorhinal cortex layer II stellate neurons die first100%

mentions🔬PSP and CBD both involve 4R-tau but produce distinct neuropa100%

derives_from?Combination studies90%

derives_from?Fasting mimetics90%

derives_from?Personalized protocols90%

derives_from?Device-assisted fasting90%

derives_from?Digital health90%

derives_from?Protocol optimization90%

derives_from?Biomarker development90%

derives_from?Precision medicine90%

derives_from?Larger clinical trials90%

see_also📖Diffusion MRI (DTI) in Neurodegeneration80%

see_also📖China Neurodegeneration Epidemiology80%

see_also📖T-Cell Dysfunction in Neurodegeneration80%

see_also📖Protein Aggregation Seeds in Neurodegeneration80%

related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition80%

related🧪Senescence-Induced Lipid Peroxidation Spreading80%

related🧪Lysosomal Enzyme Trafficking Correction80%

see_also📖Neuropil Threads in Neurodegeneration80%

see_also📖Senescent Cell Clearance in Neurodegeneration80%

related🧪Chaperone-Mediated APOE4 Refolding Enhancement80%

see_also📖Neurotensin Signaling in Neurodegeneration80%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati80%

see_also📖Neuroimaging Biomarkers for Neurodegeneration80%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration80%

related🧪R-Loop Resolution Enhancement Therapy80%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration80%

related🧪Blood-Brain Barrier SPM Shuttle System80%

see_also📖Integrated Stress Response in Neurodegeneration80%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration80%

see_also📖DALY Methodology — Neurodegeneration80%

related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu80%

related🧪Purinergic P2Y12 Inverse Agonist Therapy80%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)80%

related🧪Autophagosome Maturation Checkpoint Control80%

related🧪Ocular Immune Privilege Extension80%

related🧪RNA Granule Nucleation Site Modulation80%

related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism80%

related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi80%

related🧪Adenosine-Astrocyte Metabolic Reset80%

see_also📖PPAR Signaling Pathway in Neurodegeneration80%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen80%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering80%

related🧪Lysosomal Positioning Dynamics Modulation80%

related🧪Cryptic Exon Silencing Restoration80%

see_also📖Metal Homeostasis in Neurodegeneration80%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration80%

see_also📖IL-1 Signaling Pathway in Neurodegeneration80%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat80%

see_also📖HMGB1 Signaling in Neurodegeneration80%

see_also📖Galectin-3 Mechanism in Neurodegeneration80%

related🧪Lysosomal Membrane Repair Enhancement80%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration80%

see_also📖Microglial Priming Pathway in Neurodegeneration80%

see_also📖FA2H-Associated Neurodegeneration Pathway80%

related🧪Smartphone-Detected Motor Variability Correction80%

see_also📖Liquid Biopsy in Neurodegeneration80%

related🧪Multi-Modal Stress Response Harmonization80%

related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration80%

related🧪Glial Glycocalyx Remodeling Therapy80%

related🧪Flotillin-1 Stabilization Compounds80%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison80%

see_also📖Endocannabinoid System in Neurodegeneration80%

related🧪TFAM overexpression creates mitochondrial donor-recipient gr80%

related🧪Metabolic Switch Targeting for A1→A2 Repolarization80%

related🧪Serine/Arginine-Rich Protein Kinase Modulation80%

related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In80%

see_also📖COVID-19 Neurodegeneration Mechanism80%

see_also📖Prion Diseases in Neurodegeneration80%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain80%

related🧪Selective HDAC3 Inhibition with Cognitive Enhancement80%

related🧪Mitochondrial-Lysosomal Contact Site Engineering80%

related🧪Piezoelectric Nanochannel BBB Disruption80%

related🧪Microglial Purinergic Reprogramming80%

related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis80%

related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection80%

see_also📖Amylin Signaling in Neurodegeneration80%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration80%

related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy80%

see_also📖Exosomal miR-155 in Neurodegeneration80%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration80%

see_also📖Axon Guidance Pathways in Neurodegeneration80%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)80%

related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue80%

see_also📖Mitochondrial Fusion in Neurodegeneration80%

related🧪DNMT1-Targeting Antisense Oligonucleotide Reset80%

related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation80%

see_also📖RNA Splicing in Neurodegeneration80%

see_also📖SUMOylation in Neurodegeneration80%

related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming80%

related🧪Extracellular Matrix Stiffness Modulation80%

see_also📖Gangliosides in Neurodegeneration80%

related🧪Hypocretin-Neurogenesis Coupling Therapy80%

related🧪Lipid Droplet Dynamics as Phenotype Switches80%

related🧪SASP-Mediated Complement Cascade Amplification80%

related🧪Axonal RNA Transport Reconstitution80%

related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri80%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration80%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr80%

related🧪Synthetic Biology Rewiring via Orthogonal Receptors80%

see_also📖Paraptosis in Neurodegeneration80%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration80%

related🧪Enteric Nervous System Prion-Like Propagation Blockade80%

related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)80%

related🧪Complement C1q Mimetic Decoy Therapy80%

related🧪Circadian-Synchronized Proteostasis Enhancement80%

related🧪Complement C1q Subtype Switching80%

related🧪Orexin-Microglia Modulation Therapy80%

related🧪Nucleolar Stress Response Normalization80%

related🧪Transcriptional Autophagy-Lysosome Coupling80%

related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu80%

see_also📖Prion Protein Metabolism in Neurodegeneration80%

related🧪Sphingomyelin Synthase Activators for Raft Remodeling80%

related🧪CX43 hemichannel engineering enables size-selective mitochon80%

related🧪Mitochondrial RNA Granule Rescue Pathway80%

related🧪Aquaporin-4 Polarization Rescue80%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration80%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 80%

see_also📖Dystrophic Neurites in Neurodegeneration80%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides80%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)80%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming80%

related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation80%

related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists80%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 80%

related🧪KDM6A-Mediated H3K27me3 Rejuvenation80%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration80%

related🧪Sphingolipid Metabolism Reprogramming80%

see_also📖Therapeutic Targets in Neurodegeneration80%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)80%

related🧪Selective Acid Sphingomyelinase Modulation Therapy80%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread80%

related🧪Mechanosensitive Ion Channel Reprogramming80%

related🧪Netrin-1 Gradient Restoration80%

see_also📖Sex Differences in Neurodegeneration80%

related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor80%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio80%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration80%

related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem80%

see_also📖Manganese-Related Neurodegeneration (Manganism)80%

see_also📖Prognostic Biomarkers in Neurodegeneration80%

related🧪Chromatin Accessibility Restoration via BRD4 Modulation80%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones80%

related🧪Stress Granule Phase Separation Modulators80%

related🧪SASP-Driven Aquaporin-4 Dysregulation80%

related🧪Near-infrared light therapy stimulates COX4-dependent mitoch80%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration80%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration80%

see_also📖Nitric Oxide Signaling in Neurodegeneration80%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration80%

related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics80%

see_also📖Copper Homeostasis in Neurodegeneration80%

related🧪Ephrin-B2/EphB4 Axis Manipulation80%

related🧪Temporal TET2-Mediated Hydroxymethylation Cycling80%

see_also📖Advanced Glycation End Products in Neurodegeneration80%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a80%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration80%

related🧪Digital Twin-Guided Metabolic Reprogramming80%

related🧪Glymphatic System-Enhanced Antibody Clearance Reversal80%

related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho80%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration80%

see_also📖Hippocampal Neurogenesis in Neurodegeneration80%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction80%

see_also📖R-Loop Stress in Neurodegeneration80%

see_also📖Neuroimaging for Parkinsonian Syndromes (NCT03872102)80%

see_also📖Antibody Therapy in Neurodegeneration80%

see_also📖MicroRNA Dysfunction in Neurodegeneration80%

related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai80%

see_also📖Computational Disease Models for Neurodegeneration80%

see_also📖Progesterone Signaling Pathway in Neurodegeneration80%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration80%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su80%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration80%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration80%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration80%

see_also📖acetylcholine-signaling-neurodegeneration80%

related🧪Competitive APOE4 Domain Stabilization Peptides80%

related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m80%

see_also📖NRF2 Signaling Pathway in Neurodegeneration80%

see_also📖European Neurodegeneration Epidemiology80%

see_also📖RAN Translation in Neurodegeneration80%

see_also📖Glycosylation in Neurodegeneration80%

related🧪RAB27A-dependent extracellular vesicle engineering for mitoc80%

related🧪Circadian-Gated Maresin Biosynthesis Amplification80%

related🧪Sleep Spindle-Synaptic Plasticity Enhancement80%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration80%

see_also📖CaMKII Signaling Pathway in Neurodegeneration80%

see_also📖Down Syndrome Neurodegeneration Pathway80%

related🧪Membrane Cholesterol Gradient Modulators80%

related🧪Perforant Path Presynaptic Terminal Protection Strategy80%

related🧪Glycine-Rich Domain Competitive Inhibition80%

see_also📖India Neurodegeneration Epidemiology80%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration80%

related🧪HDAC3-Selective Inhibition for Clock Reset80%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration80%

related🧪Pharmacological Enhancement of APOE4 Glycosylation80%

see_also📖NF-kB Signaling Pathway in Neurodegeneration80%

related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th80%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio80%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration80%

related🧪CYP46A1 Overexpression Gene Therapy80%

see_also📖Neural Circuits in Neurodegeneration80%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and80%

related🧪Arginine Methylation Enhancement Therapy80%

related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors80%

see_also📖Serotonergic Dysfunction in Neurodegeneration80%

see_also📖Sleep Dysfunction in Neurodegeneration80%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration80%

see_also📖Ribosome Dysfunction in Neurodegeneration80%

see_also📖Histone Modification Pathways in Neurodegeneration80%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration80%

related🧪Senescence-Activated NAD+ Depletion Rescue80%

see_also📖synaptic-vesicle-cycling-neurodegeneration80%

see_also📖interleukin-6-signaling-neurodegeneration80%

see_also📖Endothelin Signaling Pathway in Neurodegeneration80%

related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation80%

see_also📖Global Neurodegeneration Epidemiology80%

related🧪Mitochondrial SPM Synthesis Platform Engineering80%

related🧪Microbial Inflammasome Priming Prevention80%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration80%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration80%

see_also📖Potential Impact Measures — Neurodegeneration80%

see_also📖Japan Neurodegeneration Epidemiology80%

see_also📖Paranodal Dysfunction in Neurodegeneration80%

see_also📖Economic Burden — Neurodegeneration80%

see_also📖Pericyte Loss in Neurodegeneration80%

related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol80%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration80%

see_also📖Retinal Degeneration Pathway in Neurodegeneration80%

related🧪Vagal Afferent Microbial Signal Modulation80%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration80%

see_also📖Parthanatos in Neurodegeneration80%

see_also📖GDNF Signaling Pathway in Neurodegeneration80%

related🧪SIRT6-NAD+ Axis Enhancement Therapy80%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration80%

related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme80%

related🧪SASP-Mediated Cholinergic Synapse Disruption80%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration80%

see_also📖Sleep Disorders in Neurodegeneration80%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration80%

see_also📖Neural Circuit Disruption in Neurodegeneration80%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy80%

related🧪Heat Shock Protein 70 Disaggregase Amplification80%

related🧪Quantum Coherence Disruption in Cellular Communication80%

related🧪Retinal Vascular Microcirculation Rescue80%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 80%

see_also📖Disease Progression & Staging in Neurodegeneration80%

related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho80%

see_also📖mTOR Signaling Pathway in Neurodegeneration80%

related🧪Circadian Clock-Autophagy Synchronization80%

see_also📖epigenetics-neurodegeneration80%

see_also📖Prion-Like Spread in Neurodegeneration80%

related🧪Lysosomal Calcium Channel Modulation Therapy80%

related🧪Phase-Separated Organelle Targeting80%

see_also📖Purinergic Signaling in Neurodegeneration80%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration80%

see_also📖Neuronal Hyperexcitability in Neurodegeneration80%

see_also📖Cholinergic System Dysfunction in Neurodegeneration80%

see_also📖Orexin Signaling in Neurodegeneration80%

related🧪Biorhythmic Interference via Controlled Sleep Oscillations80%

related🧪GAP43-mediated tunneling nanotube stabilization enhances neu80%

see_also📖Short Chain Fatty Acids in Neurodegeneration80%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N80%

related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 80%

see_also📖Exosomal Biomarkers in Neurodegeneration80%

see_also📖mTOR Signaling in Neurodegeneration80%

see_also📖Autosis Pathway in Neurodegeneration80%

see_also📖Convergent Pathways in Neurodegeneration80%

see_also📖Vagus Nerve Pathway in Neurodegeneration80%

see_also📖Molecular Chaperones in Neurodegeneration80%

related🧪Nutrient-Sensing Epigenetic Circuit Reactivation80%

related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati80%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration80%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener80%

related🧪Noradrenergic-Tau Propagation Blockade80%

related🧪Epigenetic Memory Erasure via TET2 Activation80%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 80%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration80%

see_also📖PKR Pathway in Neurodegeneration80%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration80%

related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat80%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration80%

related🧪Vocal Cord Neuroplasticity Stimulation80%

related🧪Senescent Cell Mitochondrial DNA Release80%

related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution80%

see_also📖Metabolomic Biomarkers in Neurodegeneration80%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)80%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl80%

see_also📖Synaptic Biomarkers in Neurodegeneration80%

related🧪Ganglioside Rebalancing Therapy80%

related🧪Low Complexity Domain Cross-Linking Inhibition80%

related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener80%

see_also📖Tau Kinase Signaling Cascade in Alzheimer's Disease80%

see_also📖US Neurodegeneration Epidemiology80%

related🧪Mitochondrial Transfer Pathway Enhancement80%

related🧪Cross-Seeding Prevention Strategy80%

see_also📖Endosomal Sorting Defects in Neurodegeneration80%

see_also📖Digital Phenotyping in Neurodegeneration80%

related🧪Senescence-Associated Myelin Lipid Remodeling80%

see_also📖Familial vs Sporadic Neurodegeneration Comparison80%

see_also📖Protein Aggregation Comparison in Neurodegeneration80%

see_also📖RNA-Targeted Therapies in Neurodegeneration80%

see_also📖Lipid Dysregulation in Neurodegeneration80%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration80%

related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto80%

related🧪Temporal Decoupling via Circadian Clock Reset80%

related🧪Purinergic Signaling Polarization Control80%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration80%

see_also📖Neuropeptide Y Signaling in Neurodegeneration80%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer80%

related🧪PARP1 Inhibition Therapy80%

related🧪TET2-Mediated Demethylation Rejuvenation Therapy80%

related🧪Circadian Rhythm Entrainment of Reactive Astrocytes80%

see_also📖Kidney-Brain Neurodegeneration Axis80%

related🧪Circadian-Synchronized LRP1 Pathway Activation80%

related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination80%

see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE75%

see_also📖UPenn Observational Research Repository (NCT04715399)75%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

see_also📖APOE4 (Apolipoprotein E4)70%

related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise70%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

mentions🧪Microbial Inflammasome Priming Prevention69%

mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna69%

mentions🧪Vagal Afferent Microbial Signal Modulation68%

see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial65%

see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739265%

see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St65%

see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime65%

see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 65%

mentions🧪Vocal Cord Neuroplasticity Stimulation63%

related🧪Microbial Inflammasome Priming Prevention62%

related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna62%

related🧪Vagal Afferent Microbial Signal Modulation61%

see_also📖nct0550878960%

see_also📖SNCA Gene Variants and Mutations60%

see_also📖MK-1167 Phase 2 AD Trial (MK-1167-008)60%

see_also📖APOE2 (Apolipoprotein E2)60%

see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas60%

see_also📖SNCA — Alpha-Synuclein Gene Entity Page60%

see_also📖PSP Liquid-Liquid Phase Separation and Biomolecular Condensa60%

see_also📖APOE3 (Apolipoprotein E3)60%

see_also📖CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD60%

see_also📖PI-2620 Tau PET Phase 3 (NCT05456503) - FTLD and Atypical AD60%

see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M60%

see_also📖remternetug-anti-amyloid-alzheimers60%

see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc60%

related🧫Experiment Index60%

related🧫Proposed experiment from debate on Perivascular spaces and g60%

related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 60%

related🧫Proposed experiment from debate on Senolytics targeting p16/60%

related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka60%

related🧫Proposed experiment from debate on Microglia activate astroc60%

related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo60%

related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P60%

related🧫Genetic Risk Modifiers in DLB Phenotype60%

related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 60%

related🧫Proposed experiment from debate on Mitochondrial transfer be60%

related🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr60%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur60%

related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre60%

related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin60%

related🧫DLB Cognitive Fluctuation Mechanism Experiment60%

related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an60%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur60%

related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal60%

related🧫Proposed experiment from debate on Epigenetic clocks and bio60%

related🧫Tau Pathology Initiation Zone Identification60%

related🧫Proposed experiment from debate on Mitochondrial transfer be60%

related🧫s:** - Dose-response studies showing therapeutic window with60%

related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional60%

related🧫s:** - Compare uptake with/without magnetic particles using 60%

related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras60%

related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi60%

related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M60%

related🧫Proposed experiment from debate on Perivascular spaces and g60%

related🧫Tau Co-Pathology in DLB Clinical Heterogeneity60%

related🧫s:** - Test MCU overexpression specifically in layer II neur60%

related🧫NPH Glymphatic System Interaction Experiment60%

related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel60%

related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in60%

related🧫Prion Strain Diversity and Selective Vulnerability in CJD60%

related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design60%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l60%

related🧫s:** - Biochemical binding assays measuring PROTAC selectivi60%

related🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment60%

related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G60%

related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec60%

related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati60%

related🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro60%

related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy60%

related🧫Experiment Scoring Methodology60%

related🧫Protein Aggregation Kinetic Validation Results60%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l60%

related🧫Epigenetic Dysregulation in Huntington's Disease — Ther60%

related🧫Proposed experiment from debate on Epigenetic clocks and bio60%

related🧫s:** - Test tau spreading in AQP4 knockout vs wild-type mice60%

related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal60%

related🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 60%

related🧫s:** - Temporal analysis showing mitochondrial defects prece60%

related🧪Vocal Cord Neuroplasticity Stimulation56%

see_also📖Long-term Effects of Hearing Intervention on Brain Health in55%

see_also📖Multimodal Diagnostic Algorithm for CBS and PSP55%

related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 54%

related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal54%

related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel54%

related🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr54%

related🧫s:** - Dose-response studies showing therapeutic window with54%

related🧫Proposed experiment from debate on Microglia activate astroc54%

related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati54%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur54%

related🧫Proposed experiment from debate on Epigenetic clocks and bio54%

related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 54%

related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P54%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l54%

related🧫Proposed experiment from debate on Mitochondrial transfer be54%

related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec54%

related🧫Experiment Index54%

related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M54%

related🧫DLB Cognitive Fluctuation Mechanism Experiment54%

related🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro54%

related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy54%

related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras54%

related🧫Proposed experiment from debate on Mitochondrial transfer be54%

related🧫s:** - Temporal analysis showing mitochondrial defects prece54%

related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional54%

related🧫s:** - Biochemical binding assays measuring PROTAC selectivi54%

related🧫s:** - Test tau spreading in AQP4 knockout vs wild-type mice54%

related🧫Protein Aggregation Kinetic Validation Results54%

related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin54%

related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka54%

related🧫Proposed experiment from debate on Perivascular spaces and g54%

related🧫Epigenetic Dysregulation in Huntington's Disease — Ther54%

related🧫Genetic Risk Modifiers in DLB Phenotype54%

related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G54%

related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an54%

related🧫Tau Pathology Initiation Zone Identification54%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l54%

related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo54%

related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre54%

related🧫s:** - Test MCU overexpression specifically in layer II neur54%

related🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment54%

related🧫Tau Co-Pathology in DLB Clinical Heterogeneity54%

related🧫Proposed experiment from debate on Perivascular spaces and g54%

related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in54%

related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi54%

related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal54%

related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design54%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur54%

related🧫Proposed experiment from debate on Senolytics targeting p16/54%

related🧫NPH Glymphatic System Interaction Experiment54%

related🧫s:** - Compare uptake with/without magnetic particles using 54%

related🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 54%

related🧫Prion Strain Diversity and Selective Vulnerability in CJD54%

related🧫Proposed experiment from debate on Epigenetic clocks and bio54%

related🧫Experiment Scoring Methodology54%

see_also📖Glymphatic and Vascular Clearance Dysfunction in 4R-Tauopath50%

mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%

related🔬Senescent cell clearance as neurodegeneration therapy50%

mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%

mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis50%

related🔬What are the mechanisms underlying selective vulnerability o50%

mentions🧪Noradrenergic-Tau Propagation Blockade50%

mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%

mentions🧪HDAC3-Selective Inhibition for Clock Reset50%

mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

mentions🧪Mitochondrial RNA Granule Rescue Pathway50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement50%

related🔬What are the mechanisms underlying sleep disruption as cause50%

mentions🧪Pharmacological Enhancement of APOE4 Glycosylation50%

mentions🧪Gut Barrier Permeability-α-Synuclein Axis Modulation50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%

see_also📖CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subc50%

mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists50%

mentions🧪Arginine Methylation Enhancement Therapy50%

see_also📖PSP and Idiopathic Normal Pressure Hydrocephalus: Clinical O50%

mentions🔬Epigenetic reprogramming in aging neurons50%

see_also📖Rigidity in Corticobasal Syndrome50%

see_also📖Digital Therapeutic Platform for Swallowing and Drooling Pro50%

mentions🧪Complement C1q Subtype Switching50%

mentions🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model50%

mentions🧪Piezoelectric Nanochannel BBB Disruption50%

mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%

mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

mentions🧫Leukocyte gene expression analysis in COVID-19 patients50%

related🔬Epigenetic reprogramming in aging neurons50%

mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

mentions🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat50%

see_also📖Neuroinflammation in Parkinson's Disease Dementia and D50%

related🔬What are the mechanisms underlying selective vulnerability o50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

see_also📖al002-trem2-agonist-alzheimers50%

mentions🧪Phase-Separated Organelle Targeting50%

see_also📖Braak Staging and Tau Propagation Pathway50%

related🔬What are the mechanisms underlying synaptic pruning by micro50%

mentions🧪Ganglioside Rebalancing Therapy50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%

mentions🧪Mechanosensitive Ion Channel Reprogramming50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%

mentions🔬What are the mechanisms underlying selective vulnerability o50%

see_also📖CBS/PSP Panxoneopathy and Membrane Biology50%

mentions🧪Microglial Purinergic Reprogramming50%

see_also📖PCDH19-Related Epilepsy (EFMR) — Preclinical Gene Therapy Pr50%

mentions🧪SASP-Mediated Complement Cascade Amplification50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

mentions🧪Lipid Droplet Dynamics as Phenotype Switches50%

mentions🧪Sleep Spindle-Synaptic Plasticity Enhancement50%

mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%

mentions🔬What are the mechanisms underlying perivascular spaces and g50%

mentions🧪Axonal RNA Transport Reconstitution50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

mentions🧪Lysosomal Enzyme Trafficking Correction50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Nucleolar Stress Response Normalization50%

mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%

mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%

mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics50%

mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio50%

mentions🔬Extracellular vesicle biomarkers for early AD detection50%

mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%

mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%

mentions🔬Senescent cell clearance as neurodegeneration therapy50%

mentions🧪Netrin-1 Gradient Restoration50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

mentions🔬Investigate prion-like spreading of tau pathology through co50%

see_also📖Geniposide for Alzheimer's disease - immune biomarker t50%

mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho50%

see_also📖APOE4 and Alzheimer's Disease Risk50%

mentions🔬What are the mechanisms underlying synaptic pruning by micro50%

see_also📖Pesticides and Parkinson Disease (Pest-PD) — NCT0642031050%

mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%

mentions🧪Circadian-Synchronized LRP1 Pathway Activation50%

mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%

see_also📖Metabolic Dysfunction and Insulin Resistance in Progressive 50%

mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

see_also📖ALS Therapeutic Landscape — Programs by Phase and Modality50%

mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%

see_also📖Systemic Infection and Tau Pathology Acceleration50%

mentions🧪Quantum Coherence Disruption in Cellular Communication50%

mentions🧪Circadian Clock-Autophagy Synchronization50%

mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%

mentions🧪CX43 hemichannel engineering enables size-selective mitochon50%

mentions🧪Lysosomal Positioning Dynamics Modulation50%

mentions🧪Circadian-Gated Maresin Biosynthesis Amplification50%

mentions🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution50%

related🧪APOE-Dependent Autophagy Restoration50%

mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%

mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp50%

mentions🧪Mitochondrial SPM Synthesis Platform Engineering50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

see_also📖A Multicenter, Phase III, Randomized, Double Blind, Placebo-50%

mentions🧪Temporal Decoupling via Circadian Clock Reset50%

see_also📖Healthcare Economics and Cost of Illness in Progressive Supr50%

mentions🧪Stress Granule Phase Separation Modulators50%

see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh50%

see_also📖GBA Glucocerebrosidase Dysfunction and Parkinson's Dise50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%

mentions🧪Mitochondrial-Lysosomal Contact Site Engineering50%

mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%

mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu50%

related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%

mentions🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection50%

mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%

mentions🧪Flotillin-1 Stabilization Compounds50%

mentions🧪PARP1 Inhibition Therapy50%

mentions🧪Purinergic Signaling Polarization Control50%

mentions🧪Blood-Brain Barrier SPM Shuttle System50%

mentions🧪Glycine-Rich Domain Competitive Inhibition50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

see_also📖Synaptic Loss and Dysfunction Pathway50%

mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%

mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%

mentions🧪Lysosomal Calcium Channel Modulation Therapy50%

mentions🧪Cross-Seeding Prevention Strategy50%

related🔬Epigenetic reprogramming in aging neurons50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

see_also📖A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month50%

related🔬Investigate prion-like spreading of tau pathology through co50%

mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%

mentions🧪Autophagosome Maturation Checkpoint Control50%

mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%

mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%

mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

mentions🧪Ephrin-B2/EphB4 Axis Manipulation50%

mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho50%

see_also📖Glymphatic Clearance Hypothesis — Impaired Aβ and Tau Remova50%

mentions🧪Membrane Cholesterol Gradient Modulators50%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides50%

see_also📖Tau Seeding and Propagation Pathway50%

mentions🧪SASP-Mediated Cholinergic Synapse Disruption50%

mentions🧪Retinal Vascular Microcirculation Rescue50%

mentions🧫tACS Connectivity Trial in Early Alzheimer's50%

mentions🧪Sphingomyelin Synthase Activators for Raft Remodeling50%

related🔬What are the mechanisms underlying mechanistic role of apoe 50%

see_also📖A 6-month & 18-month Prospective, Randomized, Placebo-co50%

mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%

mentions🧪Multi-Modal Stress Response Harmonization50%

mentions🧪R-Loop Resolution Enhancement Therapy50%

mentions🧪Lysosomal Membrane Repair Enhancement50%

mentions🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci50%

mentions🧪Reelin-Mediated Cytoskeletal Stabilization Protocol50%

mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%

mentions🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%

mentions🧪Extracellular Matrix Stiffness Modulation50%

mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%

mentions🧪Low Complexity Domain Cross-Linking Inhibition50%

mentions🧪Orexin-Microglia Modulation Therapy50%

see_also📖Shared Mechanisms Between Alzheimer and Parkinson Disease50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors50%

see_also📖Mirror Therapy and Sensory Re-education in Corticobasal Synd50%

mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

see_also📖Speech Therapy and Communication Aids in Corticobasal Syndro50%

mentions🧪Mitochondrial Transfer Pathway Enhancement50%

mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa50%

mentions🧪Glial Glycocalyx Remodeling Therapy50%

mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

see_also📖Phase 3 Study to Compare the Efficacy and Safety of Masitini50%

mentions🔬What are the mechanisms underlying apoe4 structural biology 50%

mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

see_also📖Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pi50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

see_also📖Hereditary Sensory and Autonomic Neuropathy (HSAN)50%

mentions🧪Senescence-Induced Lipid Peroxidation Spreading50%

see_also📖p-Tau Biomarker in Immunoglobulin Light Chain and Transthyre50%

see_also📖Glial Tau Pathology in PSP and CBD50%

related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%

mentions🧪Enteric Nervous System Prion-Like Propagation Blockade50%

mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

mentions🧪Transcriptional Autophagy-Lysosome Coupling50%

mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation50%

mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr50%

mentions🧪Digital Twin-Guided Metabolic Reprogramming50%

mentions🧪Senescence-Activated NAD+ Depletion Rescue50%

mentions🧪Circadian-Synchronized Proteostasis Enhancement50%

see_also📖Physical and Occupational Therapy in Corticobasal Syndrome50%

related🔬What are the mechanisms underlying synaptic pruning by micro50%

mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In50%

mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%

mentions🧪RNA Granule Nucleation Site Modulation50%

mentions🧪Complement C1q Mimetic Decoy Therapy50%

mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors50%

mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%

related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto50%

mentions🧪Adenosine-Astrocyte Metabolic Reset50%

mentions🧪Senescent Cell Mitochondrial DNA Release50%

see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 50%

mentions🧪Aquaporin-4 Polarization Rescue50%

mentions🧪Ocular Immune Privilege Extension50%

mentions🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme50%

mentions🧪Senescence-Associated Myelin Lipid Remodeling50%

see_also📖Blood-Brain Barrier Dysfunction and Therapeutic Delivery for50%

mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%

see_also📖Utilisation of Health Services and Quality of Life in Atypic50%

mentions🧪CYP46A1 Overexpression Gene Therapy50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

mentions🔬What are the mechanisms underlying rna binding protein dysre50%

mentions🧪Epigenetic Memory Erasure via TET2 Activation50%

related🔬What are the mechanisms underlying sleep disruption as cause50%

see_also📖MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acid50%

mentions🧪Smartphone-Detected Motor Variability Correction50%

mentions🧪Cryptic Exon Silencing Restoration50%

see_also📖Blood-Brain Barrier and Neuroimmune Interface in CBS/PSP50%

mentions🔬What are the mechanisms underlying what are the mechanisms b50%

mentions🧪Sphingolipid Metabolism Reprogramming50%

mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%

related🔬Extracellular vesicle biomarkers for early AD detection50%

mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%

related🔬Analyze the spectrum of microglial activation states (DAM, h50%

mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%

see_also📖Voice and Speech in Corticobasal Syndrome45%

see_also📖Multi-Analyte Biomarker Panel for Parkinson's Disease D45%

see_also📖Quality of Life and Caregiver Burden in PSP (NCT03638505)45%

see_also📖Clinical Efficacy and Mechanism of tDCS for Dysphagia in Par45%

see_also📖Investment Landscape: Frontotemporal Dementia45%

see_also📖Postural Dysfunction and Abnormalities in Corticobasal Syndr45%

see_also📖Caregiver Support and Palliative Care in Atypical [Parkinson45%

see_also📖LRRK2 Gene Variants and Mutations45%

see_also📖NLRP3 Inflammasome Inhibitors for Parkinson's Disease45%

see_also📖Imaging Biomarkers for Corticobasal Syndrome and Progressive45%

see_also📖ABCA7 Lipid Transport and Microglial Phagocytosis AD Causal 45%

see_also📖Iron and Neuromelanin Accumulation in PSP45%

see_also📖A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-C45%

see_also📖A Phase III, Randomized, Double-Blind, Placebo-Controlled, M45%

see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451645%

see_also📖Neuroresilience Mechanisms and Evidence45%

see_also📖Clinical Phenotypes and Subtypes of Corticobasal Syndrome45%

see_also📖Sleep Architecture Changes in CBS and PSP45%

see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers45%

see_also📖Japanese and German Case Series in Corticobasal Degeneration45%

see_also📖Callosal Disconnection and Interhemispheric Dysfunction in C45%

see_also📖Investment Landscape: ALS45%

see_also📖BLAAC PD - Black and African Americans Connections to PD (NC45%

see_also📖FTLD-TDP Subtypes and Mechanisms45%

see_also📖Silymarin for Neuroprotection and Symptom Management in Park45%

see_also📖HIV-Associated Neurocognitive Disorders (HAND)45%

see_also📖Alpha-Synuclein Seeding Assays (RT-QuIC and PMCA)45%

see_also📖FTDP-17 Clinical Phenotypes and Disease Progression45%

see_also📖Safety and Clinical Outcomes Study: Amniotic and Umbilical C45%

see_also📖Pupillary and Visual Dysfunction in Progressive Supranuclear45%

see_also📖TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain45%

see_also📖Vocational Rehabilitation and Driving in Corticobasal Syndro45%

see_also📖Alpha-Synuclein PET Imaging and Biomarker Advances45%

see_also📖GBA Brain Molecular Imaging and Blood Biomarkers for Precisi45%

see_also📖Somatic Mutations and Brain Mosaicism45%

see_also📖Pseudobulbar Affect and Emotional Lability in Corticobasal S45%

see_also📖Gait and Upper Limb Evaluation in PSP (NCT07136844)45%

see_also📖Aquaporin-4 (AQP4) - Glymphatic System Biomarker45%

see_also📖Whole-Body Photobiomodulation for Motor and Cognitive Change45%

see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di45%

see_also📖Social Behaviors and Quality of Life in Parkinson's Dis45%

see_also📖Advanced Proteolysis and Ubiquitin System Targeting in CBS/P45%

see_also📖Hemiballismus and Hemichorea in Corticobasal Syndrome45%

see_also📖Gait and Balance Disorders in Progressive Supranuclear Palsy45%

see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI45%

see_also📖ALS Biomarkers and Disease Monitoring45%

see_also📖Investment Landscape: Huntington's Disease45%

see_also📖A Phase 3, Randomized, Double-blind, Placebo-controlled, Par45%

see_also📖Sandhoff Disease45%

see_also📖Jervell and Lange-Nielsen Syndrome45%

see_also📖Cognitive and Speech Rehabilitation in CBS (NCT05823421)45%

see_also📖LRRK2 Kinase Activation and Endolysosomal Dysfunction in Par45%

see_also📖SNCA A53T45%

see_also📖Quality of Life and Caregiver Burden in Progressive Supranuc45%

see_also📖Trontinemab (RO7126209) Phase 3 Trial — TRONTIER 2 (NCT0717045%

see_also📖PSP Lysosomal Dysfunction and Autophagy Impairment45%

see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime45%

see_also📖Investment Landscape: Parkinson's Disease45%

see_also📖alexander-disease45%

see_also📖HLA Haplotypes and Neuroinflammatory Profiles in PSP45%

see_also📖Speech and Voice Disorders in PSP45%

see_also📖UB-311 Alzheimer's Vaccination Trial45%

see_also📖Sialorrhea and Drooling in Corticobasal Syndrome45%

see_also📖PSP Tau Propagation and Spreading Mechanisms45%

see_also📖Myoclonus and Cortical Hyperexcitability in Corticobasal Syn45%

see_also📖C9orf72 Repeat Expansions in CBS and PSP45%

see_also📖MSA Clinical Features and Diagnosis45%

see_also📖First-in-Human 4R Tau Ligand Study in PSP (NCT07348276)45%

see_also📖Caregiver Burden and Support in Corticobasal Syndrome45%

see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease45%

see_also📖VEGF and Angiogenesis Dysregulation in CBS/PSP45%

see_also📖Gait Analysis Parameter and Upper Limb Evaluation in Neurolo45%

see_also📖NLRP3 Inhibitors in Parkinson's Disease: Research and C45%

see_also📖Pupillometry and Chromatic Pupillometry in Corticobasal Synd45%

see_also📖Dysphagia and Nutritional Management in Corticobasal Syndrom45%

see_also📖Simultanagnosia and Balint's Syndrome in Corticobasal S45%

see_also📖Clostridium Butyricum for Motor and Non-motor Symptoms in Pa45%

see_also📖Environmental Toxins and Parkinson's Risk45%

see_also📖Speech and Language Deficits in Corticobasal Syndrome45%

see_also📖DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulat45%

see_also📖ATP13A9 and Parkinson's Disease45%

see_also📖TARDBP Mutations in Amyotrophic Lateral Sclerosis45%

see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease45%

see_also📖Donanemab TRAILBLAZER-ALZ 2 Trial45%

see_also📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy45%

see_also📖CNversyt and Megan Rodden ALS Trials45%

see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease45%

see_also📖Natural History and Prognosis of Corticobasal Syndrome45%

see_also📖PSP Weight Loss and Cachexia45%

see_also📖Polygenic Risk Score Integration Panel for Alzheimer's 45%

see_also📖mTOR Signaling in Autophagy and Lysosomal Function45%

see_also📖AAIC 2026: Tau-PET Imaging and Fluid Biomarker Integration45%

see_also📖Alexander Disease Genetic Variants45%

see_also📖Nutritional Support and Dietary Interventions in Corticobasa45%

mentions🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise44%

mentions🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa44%

mentions🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P44%

mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise44%

mentions🧫Gandouling protection against brain injury in Wilson's 44%

related🧪Circadian Rhythm Entrainment of Reactive Astrocytes40%

related🧪Competitive APOE4 Domain Stabilization Peptides40%

related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination40%

mentions🔬What are the mechanisms underlying digital biomarkers and ai40%

related🧪Cryptic Exon Silencing Restoration40%

related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection40%

related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto40%

related🧪Selective HDAC3 Inhibition with Cognitive Enhancement40%

related🧪Purinergic Signaling Polarization Control40%

related🧪CYP46A1 Overexpression Gene Therapy40%

related🧪SASP-Driven Aquaporin-4 Dysregulation40%

related🧪Epigenetic Memory Erasure via TET2 Activation40%

related🧪Orexin-Microglia Modulation Therapy40%

related🧪RNA Granule Nucleation Site Modulation40%

related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati40%

related🧪Digital Twin-Guided Metabolic Reprogramming40%

related🧪Lysosomal Enzyme Trafficking Correction40%

mentions🔬What are the mechanisms underlying microglia-astrocyte cross40%

related🧪Multi-Modal Stress Response Harmonization40%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides40%

related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho40%

related🧪Synthetic Biology Rewiring via Orthogonal Receptors40%

related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi40%

related🧪Chaperone-Mediated APOE4 Refolding Enhancement40%

related🧪Stress Granule Phase Separation Modulators40%

related🧪Temporal Decoupling via Circadian Clock Reset40%

related🧪Ocular Immune Privilege Extension40%

related🧪Noradrenergic-Tau Propagation Blockade40%

related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu40%

mentions🔬Analyze the spectrum of microglial activation states (DAM, h40%

related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis40%

related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation40%

related🧪Smartphone-Detected Motor Variability Correction40%

related🧪Transcriptional Autophagy-Lysosome Coupling40%

related🧪Mechanosensitive Ion Channel Reprogramming40%

related🧪Complement C1q Subtype Switching40%

related🧪Mitochondrial-Lysosomal Contact Site Engineering40%

related🧪DNMT1-Targeting Antisense Oligonucleotide Reset40%

related🧪TFAM overexpression creates mitochondrial donor-recipient gr40%

related🧪Biorhythmic Interference via Controlled Sleep Oscillations40%

related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue40%

related🧪KDM6A-Mediated H3K27me3 Rejuvenation40%

related🧪Phase-Separated Organelle Targeting40%

related🧪Arginine Methylation Enhancement Therapy40%

related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors40%

related🧪PARP1 Inhibition Therapy40%

related🧪Membrane Cholesterol Gradient Modulators40%

related🧪Enteric Nervous System Prion-Like Propagation Blockade40%

related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation40%

related🧪CX43 hemichannel engineering enables size-selective mitochon40%

related🧪Sphingolipid Metabolism Reprogramming40%

mentions🔬What are the mechanisms underlying mechanistic role of apoe 40%

related🧪Near-infrared light therapy stimulates COX4-dependent mitoch40%

related🧪Aquaporin-4 Polarization Rescue40%

related🧪Lysosomal Positioning Dynamics Modulation40%

related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy40%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer40%

related🧪Selective Acid Sphingomyelinase Modulation Therapy40%

related🧪Flotillin-1 Stabilization Compounds40%

related🧪Lipid Droplet Dynamics as Phenotype Switches40%

related🧪Lysosomal Calcium Channel Modulation Therapy40%

mentions🔬What are the mechanisms underlying blood-brain barrier trans40%

related🧪Sleep Spindle-Synaptic Plasticity Enhancement40%

related🧪Serine/Arginine-Rich Protein Kinase Modulation40%

related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%

related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 40%

related🧪Heat Shock Protein 70 Disaggregase Amplification40%

related🧪Senescence-Induced Lipid Peroxidation Spreading40%

related🧪Senescence-Activated NAD+ Depletion Rescue40%

related🧪Glial Glycocalyx Remodeling Therapy40%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%

related🧪Microglial Purinergic Reprogramming40%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones40%

related🧪Sphingomyelin Synthase Activators for Raft Remodeling40%

related🧪Circadian-Gated Maresin Biosynthesis Amplification40%

related🧪Piezoelectric Nanochannel BBB Disruption40%

related🧪Mitochondrial Transfer Pathway Enhancement40%

related🧪Ganglioside Rebalancing Therapy40%

related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution40%

related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists40%

related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat40%

related🧪Pharmacological Enhancement of APOE4 Glycosylation40%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction40%

mentions🔬What are the mechanisms underlying epigenetic clocks and bio40%

related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)40%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy40%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%

related🧪Complement C1q Mimetic Decoy Therapy40%

related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

related🧪Circadian Clock-Autophagy Synchronization40%

related🧪Hypocretin-Neurogenesis Coupling Therapy40%

related🧪Mitochondrial RNA Granule Rescue Pathway40%

mentions🔬Investigate how lipid raft composition (cholesterol metaboli40%

related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation40%

related🧪SIRT6-NAD+ Axis Enhancement Therapy40%

related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming40%

mentions🔬What are the mechanisms underlying senolytic therapy for age40%

related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%

related🧪Netrin-1 Gradient Restoration40%

related🧪Circadian-Synchronized Proteostasis Enhancement40%

related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%

related🧪Senescence-Associated Myelin Lipid Remodeling40%

related🧪GAP43-mediated tunneling nanotube stabilization enhances neu40%

mentions🔬What are the mechanisms underlying sleep disruption as cause40%

related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu40%

related🧪TET2-Mediated Demethylation Rejuvenation Therapy40%

mentions🔬What are the mechanisms underlying astrocyte reactivity subt40%

related🧪Lysosomal Membrane Repair Enhancement40%

related🧪Blood-Brain Barrier SPM Shuttle System40%

related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor40%

related🧪SASP-Mediated Cholinergic Synapse Disruption40%

related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri40%

related🧪Senescent Cell Mitochondrial DNA Release40%

related🧪Metabolic Switch Targeting for A1→A2 Repolarization40%

related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol40%

related🧪Extracellular Matrix Stiffness Modulation40%

related🧪SASP-Mediated Complement Cascade Amplification40%

related🧪Mitochondrial SPM Synthesis Platform Engineering40%

related🧪Glycine-Rich Domain Competitive Inhibition40%

related🧪R-Loop Resolution Enhancement Therapy40%

related🧪Retinal Vascular Microcirculation Rescue40%

related🧪Ephrin-B2/EphB4 Axis Manipulation40%

related🧪Nucleolar Stress Response Normalization40%

mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%

related🧪Quantum Coherence Disruption in Cellular Communication40%

related🧪RAB27A-dependent extracellular vesicle engineering for mitoc40%

related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme40%

related🧪Cross-Seeding Prevention Strategy40%

related🧪HDAC3-Selective Inhibition for Clock Reset40%

related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%

related🧪Low Complexity Domain Cross-Linking Inhibition40%

related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%

related🧪Axonal RNA Transport Reconstitution40%

related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In40%

related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism40%

related🧪Temporal TET2-Mediated Hydroxymethylation Cycling40%

related🧪Purinergic P2Y12 Inverse Agonist Therapy40%

related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai40%

related🧪Glymphatic System-Enhanced Antibody Clearance Reversal40%

related🧪Adenosine-Astrocyte Metabolic Reset40%

related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration40%

related🧪Circadian-Synchronized LRP1 Pathway Activation40%

related🧪Autophagosome Maturation Checkpoint Control40%

related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho40%

related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics40%

related🧪Perforant Path Presynaptic Terminal Protection Strategy40%

related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition40%

mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%

Reference URLs

Canonical (singular)/artifact/wiki-therapeutics-intermittent-fasting-neurodegenerationcanonical

Canonical (plural, REST)/artifacts/wiki-therapeutics-intermittent-fasting-neurodegenerationalias

API (JSON)/api/artifacts/wiki-therapeutics-intermittent-fasting-neurodegenerationapi

Citation — BibTeX/artifacts/wiki-therapeutics-intermittent-fasting-neurodegeneration/cite?fmt=bibtexexport

Citation — RIS/artifacts/wiki-therapeutics-intermittent-fasting-neurodegeneration/cite?fmt=risexport

Citation — CSL-JSON/artifacts/wiki-therapeutics-intermittent-fasting-neurodegeneration/cite?fmt=cslexport

Embed this artifact

Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.

HTML iframe

<iframe src="http://scidex.ai/artifact/wiki-therapeutics-intermittent-fasting-neurodegeneration?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>

Markdown link

[intermittent-fasting-neurodegeneration](http://scidex.ai/artifact/wiki-therapeutics-intermittent-fasting-neurodegeneration)

Direct URL

http://scidex.ai/artifact/wiki-therapeutics-intermittent-fasting-neurodegeneration

Preview

🔄 Adjacent Artifacts Recommended based on your interests

💬 Discussion

Loading comments...

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

intermittent-fasting-neurodegeneration

Intermittent Fasting and Time-Restricted Eating for Neurodegenerative Diseases

Intermittent Fasting and Time-Restricted Eating for Neurodegenerative Diseases

Overview

Historical Context and Scientific Foundation

Molecular Mechanisms of Neuroprotection

Autophagy Induction

Metabolic Switching and Ketogenesis

Reduction of Neuroinflammation

Neurotrophic Factor Enhancement

Protein Homeostasis and Proteostasis

Mitochondrial Biogenesis and Function

Evidence by Disease

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Other Tauopathies

Clinical Implementation

Fasting Protocols

Starting Protocol for Neurodegeneration

Practical Recommendations

Safety and Contraindications

Absolute Contraindications

Relative Contraindications

Adverse Effects

Special Populations

Biomarkers and Monitoring

Clinical Monitoring

Potential Biomarkers

Combination Approaches

Synergistic Strategies

Medication Interactions

Future Directions

Research Priorities

Emerging Areas

Conclusion

Related Pages

References

External Links

Related Hypotheses

💬 Discussion